Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 103學年度
  5. 探討台灣族群鈣離子通道基因多型性 在慢性腎臟疾病發展和紅血球生成素阻抗之角色
 
  • Details
Options

探討台灣族群鈣離子通道基因多型性 在慢性腎臟疾病發展和紅血球生成素阻抗之角色

Other Title
The Association Study between Genetics Polymorphism of Calcium Channel Transporters and the Progression of Chronic Kidney Disease and EPO Resistance in Taiwanese Population
Type
thesis
Date Issued
2015-06-20
Author(s)
呂蕙均
Advisor
張偉嶠
吳麥斯
Subjects
系所名稱:臨床藥物基因體學暨蛋白質體學碩士學位學程
Description
學位別:碩士
語文別:中文
指導教授:張偉嶠
共同指導教授:吳麥斯
口試委員:黃尚志;沈麗娟;簡淑真
中文關鍵字:慢性腎臟疾病, 末期腎臟疾病, 基因多型性, 慢性腎臟疾病發展, 紅血球生成素阻抗性, 微陣列
英文關鍵字:chronic kidney disease, end-stage renal diseases, polymorphism, CKD progression, EPO resistance, microarray
Abstract
臺灣的慢性腎臟疾病和末期腎臟疾病發生率及盛行率在世界各國中始終名列前茅,同時也是台灣人口前十大死因之一。雖然慢性腎臟疾病在台灣的治療已十分完善,在臨床上仍然觀察到一些慢性腎臟病患者病情迅速惡化與腎性貧血患者出現紅血球生成素阻抗性,其原因到目前為止尚未十分清楚。先前的研究指出鈣離子通道的單一核苷酸基因多型性與慢性腎臟疾病有關,鈣池調控型通道的Orai1參與T細胞以及腎小球細胞等非興奮性細胞之鈣池調控鈣離子流入(Store -Operated Calcium Entry, SOCE),而TRPC3、TRPC4主要參與經受體調控型通道(Receptor-Operated Ca2+ Channel, ROC)引發之鈣離子流入,TRPV5則是體內腎臟鈣離子吸收和再吸收的運輸通道,除了鈣離子運輸外,這些鈣離子通道在發炎反應中亦扮演重要角色。因此,本研究對ORAI1、TRPC3、TRPC4、TRPV5基因多型性與慢性腎臟疾病發展、紅血球生成素阻抗性之相關性進行探討。結果顯示,TRPC3 (rs 10518289)及TRPC3 (rs 906493)皆在基因型分型、顯性遺傳以及對數加成模式與罹患慢性腎臟疾病病人的腎絲球過濾率快速下降有統計上的顯著相關性,這兩個位點分別帶C等位基因(Allele)時GFR可能會下降得較快;另外TRPC3 rs11732666則與紅血球生成素阻抗性有相關性,當病人的rs11732666帶C等位基因(Allele)時會有較高風險產生紅血球生成素阻抗性,故需使用較高劑量之紅血球生成素才能達到療效,本研究顯示TRPC3的基因型變異可能會影響慢性腎臟病的惡化和紅血球生成素阻抗性的產生。
URI
https://203.71.86.71/handle/123456789/57126

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback